вторник, 15 марта 2016 г.

Indiana biotech firm's cancer drug analysis gets $200K boost

Indiana biotech firm's cancer drug analysis gets $200K boost


An Indiana biotechnology company has won $200,000 in federal funding to boost its technology that could help more quickly determine which drugs may help cancer patients. The National Cancer Institute awarded West Lafayette-based KinaSense the grant to refine technology that's based on Purdue University intellectual property.



from Biotech News